| Not Yet Recruiting | Neoadjuvant Immunotherapy for Patients With High-risk Eye Melanoma Uveal Melanoma | Phase 1 | 2026-05-01 |
| Recruiting | To Evaluate the Safety and Efficacy of ADP-TILIL7 in Patients With Locally Advanced or Metastatic Melanoma Melanoma Stage III, Melanoma Stage IV, Melanoma | Phase 1 | 2025-04-01 |
| Recruiting | T-cell Therapy with CRISPR PD1-edited Tumor Infiltrating Lymphocytes for Patients with Metastatic Melanoma Melanoma Metastatic | Phase 1 | 2024-12-16 |
| Terminated | ImmPACT Expanded Multiple Antigen Specific Endogenously Derived T Cells (MASE-T) to Patients With Metastatic M Malignant Melanoma | Phase 1 | 2021-09-17 |
| Terminated | T-cell Therapy in Combination With Nivolumab, Relatlimab and Ipilimumab for Patients With Metastatic Ovarian C Metastatic Ovarian Cancer, Metastatic Fallopian Tube Cancer, Peritoneal Cancer | Phase 1 / Phase 2 | 2021-04-22 |
| Unknown | Treatment Efficacy of Corticosteroids and Mycophenolate Mofetil in Patients With Immune Related Hepatitis Hepatitis, Drug-Induced | Phase 2 | 2021-04-07 |
| Completed | Dual Vaccine Trial in Myeloproliferative Neoplasms Polycythemia Vera, Essential Thrombocythemia | Phase 1 / Phase 2 | 2019-07-10 |
| Completed | CALR Exon 9 Mutant Peptide Vaccine to Patients With CALR-mutant Myeloproliferative Neoplasms Myeloproliferative Neoplasm, Unclassifiable, Essential Thrombocythemia, Myelofibrosis | Phase 1 | 2018-06-20 |
| Recruiting | Melanoma Metastasized to the Brain and Steroids Malignant Melanoma | Phase 2 | 2018-06-06 |
| Completed | Combination Therapy With Nivolumab and PD-L1/IDO Peptide Vaccine to Patients With Metastatic Melanoma Metastatic Melanoma | Phase 1 / Phase 2 | 2018-02-22 |
| Completed | Adoptive Cell Therapy Across Cancer Diagnoses Cancer | Phase 1 / Phase 2 | 2017-10-13 |
| Completed | TIL Therapy in Combination With Checkpoint Inhibitors for Metastatic Ovarian Cancer Metastatic Ovarian Cancer | Phase 1 / Phase 2 | 2017-10-09 |
| Completed | TIL Therapy for Metastatic Renal Cell Carcinoma Metastatic Renal Cell Carcinoma | Phase 1 | 2016-12-01 |
| Completed | TIL Therapy for Metastatic Ovarian Cancer Metastatic Ovarian Cancer | Phase 1 | 2015-07-01 |
| Completed | Vemurafenib and TIL Therapy for Metastatic Melanoma Metastatic Melanoma | Phase 1 / Phase 2 | 2014-11-01 |
| Completed | Peginterferon and TIL Therapy for Metastatic Melanoma Metastatic Melanoma | Phase 1 / Phase 2 | 2014-11-01 |
| Terminated | Peptide Vaccine and Temozolomide for Metastatic Melanoma Patients Malignant Melanoma | Phase 2 | 2012-05-01 |
| Completed | Dendritic Cell Vaccination and Docetaxel for Patients With Prostate Cancer Prostatic Neoplasms | Phase 2 | 2011-10-01 |
| Completed | IDO Peptid Vaccination for Stage III-IV Non Small-cell Lung Cancer Patients. NSCLC, Lung Cancer | Phase 1 | 2010-06-01 |
| Completed | Transfected Dendritic Cell Based Therapy for Patients With Breast Cancer or Malignant Melanoma Breast Cancer, Malignant Melanoma | Phase 1 | 2009-09-01 |
| Withdrawn | Dendritic Cell Based Therapy for Breast Cancer Patients Breast Cancer | Phase 2 | 2009-07-01 |
| Withdrawn | T-cell Based Immunotherapy for Head and Neck Cancer Squamous Cell Carcinoma, Head and Neck Cancer | Phase 1 | 2009-06-01 |
| Completed | T-cell Based Immunotherapy for of Melanoma Melanoma | Phase 1 / Phase 2 | 2009-06-01 |
| Completed | Dendritic Cell Based Therapy of Renal Cell Carcinoma Advanced Renal Cell Carcinoma | Phase 1 / Phase 2 | 2004-09-01 |